research

Economic Stimulus bill signed by President Obama on Feb. 17, 2009. 

An Institution applying for or receiving PHS funding from a grant, cooperative agreement, or contract that is covered by this rule must be in full compliance no later than August 24, 2012; and immediately upon making its institutional Financial Conflict of Interest (FCOI) policy publicly accessible.

Institutions receiving research money from the National Science Foundation (NSF) must maintain and enforce a written conflict of interest policy and take steps to prevent scientific misconduct. 

Organizations wishing to use marine mammals in research must apply for and receive a permit specifying the number and kind of animals to be used and the period of time for which the permit is requested.

Any institution that engages in federally funded research involving human subjects must have an Institutional Review Board (IRB). An IRB is an administrative body established to protect the rights and welfare of human research subjects recruited to participate in research activities conducted under the auspices of the institution with which it is affiliated. 

Any institution that sponsors recombinant DNA research that is covered by the National Institutes of Health (NIH) guidelines must make sure that the appropriate level of review occurs by the Institutional Biosafety Committee, and that any required petitions are submitted to the NIH. 

This law applies to research on any product under its regulatory purview. The protection of human subjects is covered in 21 C.F.R. Parts 50 and 56. An exception from informed consent requirements for emergency research was added in October 1996, effective November 1, 1996. See 21 C.F.R. § 50.24.

These laws must be complied with when non-U.S. persons or foreign nationals are granted access to regulated products or technology by a company or institution of higher education in the United States. Under the "deemed export" rule, allowing non-U.S. persons or foreign nationals access to the product or technology may trigger the requirement to apply for a license prior to that access. 

This law required DHS to establish risk-based performance standards for security of chemical facilities. An Interim Final Rule was published on April 9, 2007. The rule requires covered chemical facilities to prepare Security Vulnerability Assessments (SVAs) that identify facility security vulnerabilities.

Under this law, all colleges and universities that possess select agents, which are certain biological agents and toxins need to register with the Secretary of the U.S. Department of Health and Human Services.